C O M M U N I C A T I O N S
fibrillar (AF) forms of AS. Such transient pre-ꢀ (see below)
conformational switching has also been detected by the sophisticated
application of FCS and FRET.6 We visualized the intermediates
by AFM (an example is shown in the SI; a detailed description
will be supplied in a separate communication) and are currently
attempting their biochemical isolation, a difficult undertaking due
to their elusive nature.6 Light scattering at 355 nm largely paralleled
the ThT signal but judging from the lower t1/2 appeared to sense
some forms of I as well as AF.12
evidence5a for immobilization of virtually all protein segments on
the nanosecond time scale.
An important practical advantage of the MFC probe is the
inherently continuous nature of the aggregation assay, providing
more detailed, multiparameter data than the usual ThT-based
sampling protocols. The procedure can be implemented on many
instrumentation platforms and is easily automated. We anticipate
that AS140-MFC and related constructs will constitute useful tools
for screening inhibitors or reversers of AS aggregation, as well as
being readily transferable to other proteins undergoing pathological
as well as functional1a,15 amyloid transitions.
Acknowledgment. We thank Drs. A. Demchenko, V. Shvad-
chak, D. Arndt-Jovin, and R. Klement for valuable discussions and
U. Plessmann for mass spectra. Supported by the Max Planck
Society (E.J.E., Partner Group grant; Toxic Protein Conformation
project); Cluster of Excellence 171 of the DFG Centre for Molecular
Physiology of the Brain (DFG CMPB); Argentine agencies Anp-
CyT, CONICET, UBA (E.J.E.). DAY received postdoctoral fel-
lowships from EU FP6 STREP Fluoromag project 037465II and
the Marie Curie Foundation.
Supporting Information Available: Synthesis and characterization
of MFC dye. Preparation of AS and labeling procedure with MFC.
Spectral properties of AS and AFM images at the different steps of
aggregation. This material is available free of charge via the Internet
Figure 2. Aggregation of 2.5% AS140-MFC + 97.5% WT AS (150 µM
total protein) at 37 °C. (A) Derived spectral signals, normalized by their
changes between the start and end of the incubation and plotted according
to their respective scales: T* peak wavelength (black curve), T* peak
intensity (red), N* peak intensity (blue). The N* peak wavelength (not
shown) did not vary significantly (433 ( 2 nm). Insert: repetitive emission
spectra during aggregation (excitation 345 nm). (B) T*/N* ratio (magenta),
scattering at 355 nm (dark cyan), and ThT signal (black dashed line, fit
according to ref 10); ThT signal of the control WT sample (red squares).
References
(1) (a) Chiti, F.; Dobson, C. M. Annu. ReV. Biochem. 2006, 75, 333. (b)
Uversky, V. N. Curr. Protein Pept. Sci. 2008, 9, 507. (c) Waxman, E. A.;
Giasson, B. I. Biochim. Biophys. Acta 2009, 1792, 616.
(2) Groenning, M. J. Chem. Biol. 2010, 3, 1.
(3) (a) Lashuel, H. A.; Hartley, D.; Petre, B. M.; Walz, T.; Lansbury, P. T., Jr.
Nature 2002, 418, 291. (b) Outeiro, T. F.; Putcha, P.; Tetzlaff, J. E.;
Spoelgen, R.; Koker, M.; Carvalho, F.; Hyman, B. T.; McLean, P. J. PLoS
One 2008, 3, e1867.
(4) Munishkina, L. A.; Fink, A. L. Biochim. Biophys. Acta 2007, 1768, 1862.
(5) (a) Thirunavukkuarasu, S.; Jares-Erijman, E. A.; Jovin, T. M. J. Mol. Biol.
2008, 378, 1064. (b) Celej, M. S.; Jares-Erijman, E. A.; Jovin, T. M.
Biophys. J. 2008, 94, 4867.
(6) Nath, S.; Meuvis, J.; Hendrix, J.; Carl, S. A.; Engelborghs, Y. Biophys. J.
2010, 98, 1.
(7) (a) Roberti, M. J.; Bertoncini, C. W.; Klement, R.; Jares-Erijman, E. A.;
Jovin, T. M. Nat. Methods 2007, 4, 345. (b) Roberti, M. J.; Morgan, M.;
Menendez, G.; Pietrasanta, L. I.; Jovin, T. M.; Jares-Erijman, E. A. J. Am.
Chem. Soc. 2009, 131, 8102.
(8) (a) Demchenko, A. P.; Mely, Y.; Duportail, G.; Klymchenko, A. S. Biophys.
J. 2009, 96, 3461. (b) Shynkar, V. V.; Klymchenko, A. S.; Kunzelmann,
C.; Duportail, G.; Muller, C. D.; Demchenko, A. P.; Freyssinet, J.-M.; Mely,
Y. J. Am. Chem. Soc. 2007, 129, 2187.
(9) (a) Enander, K.; Choulier, L.; Olsson, A. L.; Yushchenko, D. A.; Kanmert,
D.; Klymchenko, A. S.; Demchenko, A. P.; Mely, Y.; Altschuh, D.
Bioconjugate Chem. 2008, 19, 1864. (b) Klymchenko, A. S.; Shvadchak,
V. V.; Yushchenko, D. A.; Jain, N.; Mely, Y. J. Phys. Chem. B 2008, 112,
12050. (c) Shvadchak, V. V.; Klymchenko, A. S.; de Rocquigny, H.; Mely,
Y. Nucleic Acids Res. 2009, 37, e25. (d) Choulier, L.; Shvadchak, V. V.;
Naidoo, A.; Klymchenko, A. S.; Mely, Y.; Altschuh, D. Anal. Biochem.
2010, 401, 188.
The large increase in the T*/N* ratio (Figure 2B) and quantum
yield (SI) as well as the red-shifted T* band exhibited by AS140C-
MFC upon aggregation reflect a transfer of the probe to a
significantly less protic (H-bonding) and moderately less polar
environment. This conclusion is based on the comparison of the
properties of the aggregated protein with those reported for the furyl
chromone in aprotic solvents, particularly DMF and acetonitrile.11b
The conjugate of MFC with acetylcysteine also had a much a higher
T*/N* ratio (∼17) in DMF than in aqueous solution (SI). It follows
that the spectral changes in AS140C-MFC during thermal-induced
aggregation of AS to both I and AF reflect a diminished exposure
of the C-terminus to the aqueous solution. The discrepancies in
the temporal evolution of the MFC signals compared to those of
ThT and light scattering also suggest that at least some I lack the
aromatic-hydrophobic groove spanning the consecutive ꢀ-strands
proposed to constitute the minimal ThT binding site of amyloid
fibrils.13 CD spectra provided further evidence for the absence of
significant ꢀ-sheet secondary structure (SI). MFC derivatives of
cysteines introduced at positions 18 and 90 also exhibited distinctive
spectral signatures (data not shown).
(10) (a) Celej, M. S.; Caarls, W.; Demchenko, A. P.; Jovin, T. M. Biochemistry
2009, 48, 7465. (b) Caarls, W.; Celej, M. S.; Demchenko, A. P.; Jovin,
T. M. J Fluoresc 2010, 20, 181.
(11) (a) Avilov, S. V.; Bode, C. F.; Tolgyesi, G.; Klymchenko, A. S.; Fidy, J.;
Demchenko, A. P. Int. J. Biol. Macromol. 2005, 36, 290. (b) Das, R.;
Klymchenko, A. S.; Duportail, G.; Mely, Y. Photochem. Photobiol. Sci.
2009, 8, 1583.
(12) The 90° scattering measurement is more convenient than turbidity6 in that
it is obtained as an integral part of the recorded emission spectrum by
selecting a region at the red-edge of the excitation band that yields signal
levels comparable to those of fluorescence (SI).
The persistence of the enhanced MFC emission in AF is notable
in view of the conclusion from other studies, e.g. based on solid-
state NMR,14 that the C-terminus of fibrillar AS is exposed and
mobile. The temporal range of measurement is a key issue. The
steady-state fluorescence anisotropy of the T* band in the monomer
(0.20 ( 0.03) and AF (0.31 ( 0.04) were consistent with prior
(13) Wu, C.; Biancalana, M.; Koide, S.; Shea, J.-E. J. Mol. Biol. 2009, 391,
784.
(14) Heise, H.; Celej, M. S.; Becker, S.; Riedel, D.; Pelah, A.; Kumar, A.; Jovin,
T. M.; Baldus, M. J. Mol. Biol. 2008, 380, 444.
(15) Fowler, D. M.; Koulov, A. V.; Balch, W. E.; Kelly, J. W. Trends Biochem.
Sci. 2007, 32, 217.
JA102838N
9
J. AM. CHEM. SOC. VOL. 132, NO. 23, 2010 7861